Ironwood Pharmaceuticals Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2012. For the quarter, the company's revenue was $26,980,000 compared with $32,154,000 a year ago. Loss from operations was $43,900,000 compared with $7,032,000 a year ago. Net loss was $43,855,000 or $0.41 per basic and diluted share compared with net loss of $6,974,000 or $0.07 per basic and diluted share a year ago.

For the year, the company's revenue was $150,245,000 compared with $65,871,000 a year ago. Loss from operations was $72,762,000 compared with $66,142,000 a year ago. Net loss was $72,624,000 or $0.68 per basic and diluted share compared with net loss of $64,852,000 or $0.65 per basic and diluted share a year ago.